DNA & Genetics Gilead to Acquire Arcellx for $7.8B, Adding Anito-Cel to Cancer PipelineBy adminFebruary 23, 20260 A researcher working at Kite, a Gilead Company. Kite’s parent company Gilead Sciences has agreed to acquire Arcellx for $7.8…
